WHO ICTRP trial

A study of haploidentical transplantation with post-transplant cyclophosphamide…

JPRN-UMIN000030767 · Japan Primary Registries Network (JPRN) · Not Recruiting

Key facts

Trial ID JPRN-UMIN000030767
Public title A study of haploidentical transplantation with post-transplant cyclophosphamide and prophylactic donor lymphocyte infusions.
Scientific title A study of haploidentical transplantation with post-transplant cyclophosphamide and prophylactic donor lymphocyte infusions. - A study of haploidentical transplantation with post-transplant cyclophosphamide and prophylactic donor lymphocyte infusions.
Primary sponsor Department of Pediatrics, Kanazawa University Hospital
Registry Japan Primary Registries Network (JPRN)
Recruitment status Not Recruiting
Study type Interventional
Phase Not selected
Countries Japan
Conditions AML,ALL,MDS,NHL,CML Neuroblastoma,Rhabdomyosarcoma,Ewing sarcoma
Interventions GVHD prophilaxis Cyclophosphamide 50mg/kg iv day3,4(or 5) and prophylactic donor lymphocyte infusions (day21,day35 and day60)
Registration date Feb 3, 2018
Target size 8
Registry page center6.umin.ac.jp

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations